202 related articles for article (PubMed ID: 27374092)
1. β-MSCs: successful fusion of MSCs with β-cells results in a β-cell like phenotype.
Azizi Z; Lange C; Paroni F; Ardestani A; Meyer A; Wu Y; Zander AR; Westenfelder C; Maedler K
Oncotarget; 2016 Aug; 7(31):48963-48977. PubMed ID: 27374092
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of mesenchymal stem cells derived from pancreatic islets and bone marrow into islet-like cell phenotype.
Zanini C; Bruno S; Mandili G; Baci D; Cerutti F; Cenacchi G; Izzi L; Camussi G; Forni M
PLoS One; 2011; 6(12):e28175. PubMed ID: 22194812
[TBL] [Abstract][Full Text] [Related]
3. Adipose tissue-derived mesenchymal stromal cells efficiently differentiate into insulin-producing cells in pancreatic islet microenvironment both in vitro and in vivo.
Karaoz E; Okcu A; Ünal ZS; Subasi C; Saglam O; Duruksu G
Cytotherapy; 2013 May; 15(5):557-70. PubMed ID: 23388582
[TBL] [Abstract][Full Text] [Related]
4. Electrofusion of mesenchymal stem cells and islet cells for diabetes therapy: a rat model.
Yanai G; Hayashi T; Zhi Q; Yang KC; Shirouzu Y; Shimabukuro T; Hiura A; Inoue K; Sumi S
PLoS One; 2013; 8(5):e64499. PubMed ID: 23724055
[TBL] [Abstract][Full Text] [Related]
5. Generation of high-yield insulin producing cells from human bone marrow mesenchymal stem cells.
Jafarian A; Taghikhani M; Abroun S; Pourpak Z; Allahverdi A; Soleimani M
Mol Biol Rep; 2014 Jul; 41(7):4783-94. PubMed ID: 24718781
[TBL] [Abstract][Full Text] [Related]
6. PDX1- and NGN3-mediated in vitro reprogramming of human bone marrow-derived mesenchymal stromal cells into pancreatic endocrine lineages.
Limbert C; Päth G; Ebert R; Rothhammer V; Kassem M; Jakob F; Seufert J
Cytotherapy; 2011 Aug; 13(7):802-13. PubMed ID: 21506889
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow-derived mesenchymal stem cells co-cultured with pancreatic islets display β cell plasticity.
Karaoz E; Ayhan S; Okçu A; Aksoy A; Bayazıt G; Osman Gürol A; Duruksu G
J Tissue Eng Regen Med; 2011 Jun; 5(6):491-500. PubMed ID: 21604384
[TBL] [Abstract][Full Text] [Related]
8. Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation.
Karnieli O; Izhar-Prato Y; Bulvik S; Efrat S
Stem Cells; 2007 Nov; 25(11):2837-44. PubMed ID: 17615265
[TBL] [Abstract][Full Text] [Related]
9. Combined transfection of the three transcriptional factors, PDX-1, NeuroD1, and MafA, causes differentiation of bone marrow mesenchymal stem cells into insulin-producing cells.
Guo QS; Zhu MY; Wang L; Fan XJ; Lu YH; Wang ZW; Zhu SJ; Wang Y; Huang Y
Exp Diabetes Res; 2012; 2012():672013. PubMed ID: 22761608
[TBL] [Abstract][Full Text] [Related]
10. Expression of Pdx1 mediates differentiation from mesenchymal stem cells into insulin-producing cells.
Yuan H; Li J; Xin N; Zhao Z; Qin G
Mol Biol Rep; 2010 Dec; 37(8):4023-31. PubMed ID: 20306305
[TBL] [Abstract][Full Text] [Related]
11. Reprogramming of enteroendocrine K cells to pancreatic β-cells through the combined expression of Nkx6.1 and Neurogenin3, and reaggregation in suspension culture.
Lee E; Ryu GR; Moon SD; Ko SH; Ahn YB; Song KH
Biochem Biophys Res Commun; 2014 Jan; 443(3):1021-7. PubMed ID: 24365150
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro.
Rose RA; Jiang H; Wang X; Helke S; Tsoporis JN; Gong N; Keating SC; Parker TG; Backx PH; Keating A
Stem Cells; 2008 Nov; 26(11):2884-92. PubMed ID: 18687994
[TBL] [Abstract][Full Text] [Related]
13. Reprogramming human umbilical cord mesenchymal stromal cells to islet-like cells with the use of in vitro-synthesized pancreatic-duodenal homebox 1 messenger RNA.
Wang XL; Hu P; Guo XR; Yan D; Yuan Y; Yan SR; Li DS
Cytotherapy; 2014 Nov; 16(11):1519-1527. PubMed ID: 25287601
[TBL] [Abstract][Full Text] [Related]
14. Breast milk MSCs upregulated β-cells PDX1, Ngn3, and PCNA expression via remodeling ER stress /inflammatory /apoptotic signaling pathways in type 1 diabetic rats.
Khamis T; Abdelalim AF; Saeed AA; Edress NM; Nafea A; Ebian HF; Algendy R; Hendawy DM; Arisha AH; Abdallah SH
Eur J Pharmacol; 2021 Aug; 905():174188. PubMed ID: 34004210
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of PDX1 gene-modified human umbilical cord mesenchymal stem cells into insulin-producing cells in vitro.
He D; Wang J; Gao Y; Zhang Y
Int J Mol Med; 2011 Dec; 28(6):1019-24. PubMed ID: 21837359
[TBL] [Abstract][Full Text] [Related]
16. Sonic hedgehog pathway suppression and reactivation accelerates differentiation of rat adipose-derived mesenchymal stromal cells toward insulin-producing cells.
Dayer D; Tabar MH; Moghimipour E; Tabandeh MR; Ghadiri AA; Bakhshi EA; Orazizadeh M; Ghafari MA
Cytotherapy; 2017 Aug; 19(8):937-946. PubMed ID: 28647274
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic diabetic mesenchymal stem cells transplantation in streptozotocin-induced diabetic rat.
Dong QY; Chen L; Gao GQ; Wang L; Song J; Chen B; Xu YX; Sun L
Clin Invest Med; 2008 Dec; 31(6):E328-37. PubMed ID: 19032902
[TBL] [Abstract][Full Text] [Related]
18. Extracellular matrix gel is necessary for in vitro cultivation of insulin producing cells from human umbilical cord blood derived mesenchymal stem cells.
Gao F; Wu DQ; Hu YH; Jin GX
Chin Med J (Engl); 2008 May; 121(9):811-8. PubMed ID: 18701047
[TBL] [Abstract][Full Text] [Related]
19. Enhanced differentiation of human pluripotent stem cells into pancreatic progenitors co-expressing PDX1 and NKX6.1.
Memon B; Karam M; Al-Khawaga S; Abdelalim EM
Stem Cell Res Ther; 2018 Jan; 9(1):15. PubMed ID: 29361979
[TBL] [Abstract][Full Text] [Related]
20. Reduction of marginal mass required for successful islet transplantation in a diabetic rat model using adipose tissue-derived mesenchymal stromal cells.
Navaei-Nigjeh M; Moloudizargari M; Baeeri M; Gholami M; Lotfibakhshaiesh N; Soleimani M; Vasheghani-Farahani E; Ai J; Abdollahi M
Cytotherapy; 2018 Sep; 20(9):1124-1142. PubMed ID: 30068495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
